KKR & Co. Inc. (NYSE:KKR) Hits New 1-Year High – Should You Buy?

Shares of KKR & Co. Inc. (NYSE:KKR) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $149.44 and last traded at $149.33, with a volume of 358705 shares trading hands. The stock had previously closed at $138.99.

Analyst Upgrades and Downgrades

KKR has been the subject of several analyst reports. Morgan Stanley raised their price objective on KKR & Co. Inc. from $107.00 to $143.00 and gave the company an “equal weight” rating in a research note on Thursday, October 10th. TD Cowen lifted their target price on KKR & Co. Inc. from $166.00 to $184.00 and gave the stock a “buy” rating in a research report on Friday, October 25th. Redburn Atlantic assumed coverage on KKR & Co. Inc. in a research note on Tuesday, August 27th. They issued a “buy” rating and a $153.00 price objective on the stock. JMP Securities raised their target price on shares of KKR & Co. Inc. from $150.00 to $155.00 and gave the company a “market outperform” rating in a research report on Tuesday, October 29th. Finally, Hsbc Global Res raised shares of KKR & Co. Inc. to a “strong-buy” rating in a research report on Wednesday, September 18th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $151.64.

KKR & Co. Inc. Stock Up 9.6 %

The company’s 50-day moving average is $131.06 and its 200 day moving average is $116.32. The stock has a market capitalization of $135.13 billion, a PE ratio of 42.25, a price-to-earnings-growth ratio of 1.14 and a beta of 1.61. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.86.

KKR & Co. Inc. (NYSE:KKR) last issued its earnings results on Thursday, October 24th. The asset manager reported $1.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.03 by $0.35. The company had revenue of $4.79 billion during the quarter, compared to analyst estimates of $1.23 billion. KKR & Co. Inc. had a return on equity of 5.86% and a net margin of 13.21%. During the same quarter last year, the business posted $0.73 EPS. As a group, analysts anticipate that KKR & Co. Inc. will post 4.01 EPS for the current year.

KKR & Co. Inc. Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 19th. Investors of record on Monday, November 4th will be issued a $0.175 dividend. The ex-dividend date of this dividend is Monday, November 4th. This represents a $0.70 annualized dividend and a yield of 0.46%. KKR & Co. Inc.’s dividend payout ratio (DPR) is presently 21.28%.

Insider Buying and Selling at KKR & Co. Inc.

In other KKR & Co. Inc. news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the company’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $25.75, for a total value of $149,350,000.00. Following the sale, the insider now directly owns 25,260,971 shares of the company’s stock, valued at approximately $650,470,003.25. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, major shareholder Kkr Group Partnership L.P. purchased 11,619,998 shares of the stock in a transaction that occurred on Wednesday, September 11th. The shares were purchased at an average cost of $11.13 per share, with a total value of $129,330,577.74. Following the completion of the acquisition, the insider now owns 92,959,984 shares of the company’s stock, valued at approximately $1,034,644,621.92. This represents a 0.00 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of KKR & Co. Inc. stock in a transaction on Friday, September 13th. The shares were sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the completion of the transaction, the insider now directly owns 25,260,971 shares of the company’s stock, valued at $650,470,003.25. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 39.34% of the company’s stock.

Institutional Investors Weigh In On KKR & Co. Inc.

Institutional investors have recently modified their holdings of the business. Mizuho Markets Americas LLC purchased a new position in KKR & Co. Inc. during the third quarter worth approximately $423,000. Coastline Trust Co boosted its stake in shares of KKR & Co. Inc. by 61.8% in the third quarter. Coastline Trust Co now owns 22,200 shares of the asset manager’s stock worth $2,899,000 after acquiring an additional 8,481 shares during the last quarter. Signature Estate & Investment Advisors LLC increased its position in shares of KKR & Co. Inc. by 39.3% during the third quarter. Signature Estate & Investment Advisors LLC now owns 3,483 shares of the asset manager’s stock worth $455,000 after purchasing an additional 982 shares in the last quarter. Connable Office Inc. raised its stake in KKR & Co. Inc. by 0.4% in the 3rd quarter. Connable Office Inc. now owns 19,311 shares of the asset manager’s stock valued at $2,522,000 after purchasing an additional 82 shares during the last quarter. Finally, CIBC Asset Management Inc raised its stake in KKR & Co. Inc. by 9.0% in the 3rd quarter. CIBC Asset Management Inc now owns 104,399 shares of the asset manager’s stock valued at $13,632,000 after purchasing an additional 8,653 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.

KKR & Co. Inc. Company Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.